when should i take my glp 1 The biomarkers to watch you're on a GLP-1 Navigating Insurance for GLP-1 Medication:

There have been postmarketing reports of fatal events of ketoacidosis in patients with type 2 diabetes mellitus using SGLT2 inhibitors, including FARXIGA

A separate 2024 analysis in Frontiers in Endocrinology showed that 0.5 mg weekly led to sustained weight loss and metabolic improvements over 12 months in patients with type 2 diabetes

The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis

Be cautious about self-experimentation without medical oversight due to unknown risks (e.g., contamination, cancer promotion) and unregulated sourcing

You may notice appetite quieting